院内心脏骤停后儿童神经行为结局
THAPCA-IH试验纳入2009至2015年2天至18岁以下院内心脏骤停复苏后仍昏迷的儿童,比较低温(33.0°C)与常温(36.8°C)目标温度管理,主要结局无差异。本报告仅分析骤停前VABS-II综合评分≥70的269例患儿,对135例一年存活者中125例完成随访。12个月时77%(96/125)VABS-II评分≥70,59%认知综合评分在均值2SD以内;VABS-II综合、领域及多数子领域评分从骤停前至3个月和12个月均下降(综合均值约下降1个SD,p<0.005),3个月与12个月评分强相关(r=0.72,p<0.001)。
要点
- 院内心脏骤停后存活出院的昏迷患儿中,77%(96/125)在12个月时VABS-II综合评分≥70,处于大致正常范围。
- 59%的患儿12个月认知综合评分在均值2SD以内。
- VABS-II综合评分从骤停前至3个月和12个月平均下降约1个SD(p<0.005),多个功能领域均受累。
- 3个月与12个月VABS-II评分强相关(r=0.72,p<0.001),提示3个月评估可反映12个月功能水平。
- THAPCA-IH试验中低温(33.0°C)与常温(36.8°C)目标温度管理的主要结局无差异。
适用人群与场景
- 2天至<18岁儿童,院内心脏骤停复苏后仍昏迷并入选THAPCA-IH试验,2009至2015年入组。
- 本报告仅纳入骤停前VABS-II综合评分≥70(大致正常)的269例患儿。
- 随访分析对象为135例一年存活者中完成随访的125例。
诊断标准与关键阈值
- 骤停前神经行为功能采用Vineland Adaptive Behavior Scales第二版(VABS-II)评估,综合评分≥70定义为大致正常。
- 认知综合评分以≥2SD of mean为界值报告。
处置流程与药物剂量
- THAPCA-IH试验评估两种目标温度管理干预:低温33.0°C或常温36.8°C。
- VABS-II在入组后不久评估骤停前功能,并于3个月和12个月复查;12个月完成认知测试。
研究设计与关键结果
- THAPCA-IH为临床试验,纳入2天至<18岁院内心脏骤停复苏后昏迷儿童,比较低温33.0°C与常温36.8°C目标温度管理,主要结局(存活且神经行为结局良好)两组无差异。
- 本报告分析269例骤停前VABS-II综合评分≥70的患儿,135例一年存活者中125例获得随访。
- 12个月时77%(96/125)VABS-II评分≥70,59%认知综合评分在均值2SD以内。
- VABS-II综合、领域及多数子领域评分从骤停前至3个月和12个月均下降,综合均值约下降1个SD(p<0.005)。
- 3个月与12个月VABS-II评分强相关(r=0.72,p<0.001)。
证据类型、等级与局限
- 证据类型:THAPCA-IH临床试验(NCT00880087)的随访分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对院内心脏骤停后存活出院的昏迷患儿,应在3个月和12个月评估神经行为功能,因多数患儿多个功能领域较骤停前显著下降。
- 3个月VABS-II评分与12个月强相关(r=0.72),3个月评估结果可供参考。
- 约四分之三患儿12个月VABS-II综合评分处于大致正常范围,但综合均值较骤停前下降约1个SD。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Children who remain comatose after in-hospital cardiac arrest (IH-CA) resuscitation are at risk for poor neurological outcome. We report results of detailed neurobehavioural testing in paediatric IH-CA survivors, initially comatose after return of circulation, and enrolled in THAPCA-IH, a clinical trial that evaluated two targeted temperature management interventions (hypothermia, 33.0 °C or normothermia, 36.8 °C; NCT00880087).
METHODS: Children, aged 2 days to <18 years, were enrolled in THAPCA-IH from 2009 to 2015; primary trial outcome (survival with favorable neurobehavioural outcome) did not differ between groups. Pre-IH-CA neurobehavioural functioning, measured with the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) was evaluated soon after enrollment; this report includes only children with broadly normal pre-IH-CA scores (VABS-II composite scores ≥70; 269 enrolled). VABS-II was re-administered 3 and 12 months later. Cognitive testing was completed at 12 months.
RESULTS: Follow-ups were obtained on 125 of 135 eligible one-year survivors. Seventy-seven percent (96/125) had VABS-II scores ≥70 at 12 months; cognitive composites were ≥2SD of mean in 59%. VABS-II composite, domain, and most subdomain scores declined between pre-IH-CA and 3-month, and pre-IH-CA and 12-month assessments (composite means declined about 1 SD at 3 and 12 months, p < 0.005); 3 and 12-month scores were strongly correlated (r = 0.72, p < 0.001).
CONCLUSIONS: In paediatric IH-CA survivors at high risk for unfavorable outcomes, the majority demonstrated significant declines in neurobehavioural functioning, across multiple functional domains, with similar functioning at 3 and 12 months. About three-quarters attained VABS-II functional performance composite scores within the broadly normal range.
参考来源
- Slomine BS, Silverstein FS, Christensen JR, et al. Neurobehavioural outcomes in children after In-Hospital cardiac arrest. Resuscitation. 2018. PMID: 29305927. doi:10.1016/j.resuscitation.2018.01.002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。